Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Andrew Riley
CEO and GC
rileya@summitbiomedicalimaging.com

Message the company or request a 1:1 meeting here

Summit Biomedical Imaging is a clinical stage cancer diagnostics company looking to transform the oral cancer detection market by brining our first product, a fluorescent biomarker containing mouthwash for detecting oral cancer, to market by Q1 2027. Oral cancer detection is a $1B+ annual market in the U.S. At our anticipated price point for our target market segment, this is a $150M+ annual revenue opportunity in the U.S. Summit is currently conducting a Phase II clinical trial and is looking to raise $7.5M for business development. 

Executive Summary